Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Pia, Moltu"'
Autor:
Birgit Engesæter, Bianca van Diermen Hidle, Mona Hansen, Pia Moltu, Kjersti Mangseth Staby, Siri Borchgrevink-Persen, Olav K. Vintermyr, Stefan Lönnberg, Mari Nygård, Emiel A. M. Janssen, Philip E. Castle, Irene Kraus Christiansen
Publikováno v:
BMC Infectious Diseases, Vol 16, Iss 1, Pp 1-8 (2016)
Abstract Background Human papillomavirus (HPV) testing as primary screening for cervical cancer is currently being implemented in Norway in a randomized controlled fashion, involving three laboratories. As part of the quality assurance programme of t
Externí odkaz:
https://doaj.org/article/78758775caa04652966a7fe80862053e
Autor:
Irene Tveiterås Øvestad, Ingvild Dalen, Marie S. Andersland, Olav K. Vintermyr, Pia Moltu, Jannicke M. Berland, Emilius A. M. Janssen, Hans Kristian Haugland
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 8; Pages: 7158
The implementation of high-risk human papillomavirus testing (hrHPV testing) as a screening method in substitute for cytology has evoked the need for more sensitive and less objective tests for the triage of HPV-positive women. In a cohort of 1763 HP
Autor:
Melinda Lillesand, Einar Gudlaugsson, Jannicke M. Berland, Pia Moltu, Irene Kraus Christiansen, Irene T Øvestad, Emma Rewcastle, Emiel A. M. Janssen, Beatrix Bicskei
Publikováno v:
Journal of Cancer Science and Clinical Therapeutics.
The causative role of HPV infection in a wide range of diseases is well established, highlighting the importance of accurate HPV genotyping techniques applicable to various tissue types and conservation methods. This study compared the performance of
Autor:
Jannicke M. Berland, Elisabeth Hansen, Irene T Øvestad, Janne L. D. Loge, Ingvild Dalen, Britt Mona Dybdahl, Marius B. Dirdal, Pia Moltu
Publikováno v:
Cancer Cytopathology. 125:283-291
BACKGROUND More accurate biomarkers in cervical cytology screening could reduce the number of women unnecessarily referred for biopsy. This study investigated the ability of p16/Ki-67 dual staining to predict high-grade cervical intraepithelial neopl
Autor:
Stefan Lönnberg, Emiel A. M. Janssen, Irene Kraus Christiansen, Pia Moltu, Bianca van Diermen Hidle, Mona Hansen, Siri Borchgrevink-Persen, Birgit Engesæter, Kjersti M. Staby, Philip E. Castle, Olav Karsten Vintermyr, Mari Nygård
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 16, Iss 1, Pp 1-8 (2016)
BMC Infectious Diseases, Vol 16, Iss 1, Pp 1-8 (2016)
Background Human papillomavirus (HPV) testing as primary screening for cervical cancer is currently being implemented in Norway in a randomized controlled fashion, involving three laboratories. As part of the quality assurance programme of the implem
Autor:
Irene T, Ovestad, Ingvild, Dalen, Elisabeth, Hansen, Janne L D, Loge, Britt Mona, Dybdahl, Marius B, Dirdal, Pia, Moltu, Jannicke M, Berland
Publikováno v:
Cancer cytopathology. 125(4)
More accurate biomarkers in cervical cytology screening could reduce the number of women unnecessarily referred for biopsy. This study investigated the ability of p16/Ki-67 dual staining to predict high-grade cervical intraepithelial neoplasia (CIN)